Advanced search
Publication Cover
Clinical Ophthalmology Volume 14, 2020 - Issue
Submit an article Journal homepage
111
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Learning Curve and One-Year Outcome of XEN 45 Gel Stent Implantation in a Swedish Population

Tobias Busch1 Department of Ophthalmology, Region Västra Götaland, Sahlgrenska University Hospital, Mölndal, SwedenCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2459-1848View further author information
ORCID Icon,
Dragana Skiljic1 Department of Ophthalmology, Region Västra Götaland, Sahlgrenska University Hospital, Mölndal, Sweden;2 Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenORCID Iconhttps://orcid.org/0000-0002-9220-7767View further author information
ORCID Icon,
Thiemo Rudolph1 Department of Ophthalmology, Region Västra Götaland, Sahlgrenska University Hospital, Mölndal, SwedenView further author information
,
Anders Bergström1 Department of Ophthalmology, Region Västra Götaland, Sahlgrenska University Hospital, Mölndal, Sweden;3 Department of Ophthalmology, Skåne University Hospital, Lund, SwedenView further author information
&
Madeleine Zetterberg1 Department of Ophthalmology, Region Västra Götaland, Sahlgrenska University Hospital, Mölndal, Sweden;2 Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, SwedenView further author information
Pages 3719-3733 | Published online: 02 Nov 2020

References

  • Caprioli J, Kim JH, Friedman DS, et al. Special commentary: supporting innovation for safe and effective minimally invasive glaucoma surgery: summary of a joint meeting of the American Glaucoma Society and the Food and Drug Administration, Washington, DC, February 26, 2014. Ophthalmology. 2015;122(9):1795–1801. doi:10.1016/j.ophtha.2015.02.029
  • Buffault J, Baudouin C, Labbe A. XEN((R)) Gel Stent for management of chronic open angle glaucoma: a review of the literature. J Fr Ophtalmol. 2019;42(2):e37–e46. doi:10.1016/j.jfo.2018.12.002
  • Fernandez-Garcia A, Zhou Y, Garcia-Alonso M, Andrango HD, Poyales F, Garzon N. Comparing medium-term clinical outcomes following XEN(R) 45 and XEN(R) 63 device implantation. J Ophthalmol. 2020;2020:4796548. doi:10.1155/2020/4796548
  • Lavin-Dapena C, Cordero-Ros R, D’Anna O, Mogollon I. XEN 63 gel stent device in glaucoma surgery: a 5-years follow-up prospective study. Eur J Ophthalmol. 2020;1120672120952033.
  • Reitsamer H, Sng C, Vera V, et al. Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2019;257(5):983–996. doi:10.1007/s00417-019-04251-z
  • Kirwan JF, Lockwood AJ, Shah P, et al. Trabeculectomy in the 21st century: a multicenter analysis. Ophthalmology. 2013;120(12):2532–2539. doi:10.1016/j.ophtha.2013.07.049
  • Grover DS, Flynn WJ, Bashford KP, et al. Performance and safety of a new ab interno gelatin stent in refractory glaucoma at 12 months. Am J Ophthalmol. 2017;183:25–36. doi:10.1016/j.ajo.2017.07.023
  • Astrom S, Stenlund H, Linden C. Incidence and prevalence of pseudoexfoliations and open-angle glaucoma in northern Sweden: II. Results after 21 years of follow-up. Acta Ophthalmol Scand. 2007;85(8):832–837. doi:10.1111/j.1600-0420.2007.00980.x
  • Mansouri K, Gillmann K, Rao HL, Guidotti J, Mermoud A. Prospective evaluation of XEN gel implant in eyes with pseudoexfoliative glaucoma. J Glaucoma. 2018;27(10):869–873. doi:10.1097/IJG.0000000000001045
  • Gillmann K, Bravetti GE, Mermoud A, Rao HL, Mansouri K. XEN gel stent in pseudoexfoliative glaucoma: two-year results of a prospective evaluation. J Glaucoma. 2019;28(8):676–684. doi:10.1097/IJG.0000000000001295
  • Lenzhofer M, Strohmaier C, Sperl P, et al. Effect of the outer stent position on efficacy after minimally invasive transscleral glaucoma gel stent implantation. Acta Ophthalmol. 2019;97(8):e1105–e1111. doi:10.1111/aos.14167
  • Tan SZ, Walkden A, Au L. One-year result of XEN45 implant for glaucoma: efficacy, safety, and postoperative management. Eye (Lond). 2018;32(2):324–332. doi:10.1038/eye.2017.162
  • Vera V, Sheybani A, Lindfield D, Stalmans I, Ahmed IIK. Recommendations for the management of elevated intraocular pressure due to bleb fibrosis after XEN gel stent implantation. Clin Ophthalmol. 2019;13:685–694. doi:10.2147/OPTH.S195457
  • Zetterstrom C, Behndig A, Kugelberg M, Montan P, Lundstrom M. Changes in intraocular pressure after cataract surgery: analysis of the Swedish National Cataract Register Data. J Cataract Refract Surg. 2015;41(8):1725–1729. doi:10.1016/j.jcrs.2014.12.054
  • De Gregorio A, Pedrotti E, Russo L, Morselli S. Minimally invasive combined glaucoma and cataract surgery: clinical results of the smallest ab interno gel stent. Int Ophthalmol. 2018;38(3):1129–1134. doi:10.1007/s10792-017-0571-x
  • Hengerer FH, Kohnen T, Mueller M, Conrad-Hengerer I. Ab interno gel implant for the treatment of glaucoma patients with or without prior glaucoma surgery: 1-year results. J Glaucoma. 2017;26(12):1130–1136. doi:10.1097/IJG.0000000000000803
  • Widder RA, Dietlein TS, Dinslage S, Kuhnrich P, Rennings C, Rossler G. The XEN45 gel stent as a minimally invasive procedure in glaucoma surgery: success rates, risk profile, and rates of re-surgery after 261 surgeries. Graefes Arch Clin Exp Ophthalmol. 2018;256(4):765–771. doi:10.1007/s00417-018-3899-7

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.